缺血性卒中血管内取栓治疗速度的健康生命年成本:7项随机临床试验个体患者数据的荟萃分析
该研究汇总7项随机临床试验的781例接受血管内取栓的大血管闭塞性缺血性卒中患者个体数据,分析入院至再灌注各时间间隔与健康生命年损失的关系。结果显示就诊后流程延迟与健康生命年损失相关,每延迟1秒与损失2.2小时健康生命相关,尤其强调入院后时间段的持续质量改进。
要点
- 入院至穿刺每延迟10分钟,健康生命年损失1.8个月,而发病至入院延迟无显著关联。
- 每延迟1秒,入院至穿刺损失2.2小时健康生命,入院至再灌注损失2.4小时。
- 早期治疗患者中,就诊后流程延迟与更差临床结局相关,应优化入院后流程。
核心结论
- 在急性缺血性卒中取栓患者中,就诊后流程延迟与健康生命年损失相关,尤其入院至干预时间段。
- 每延迟1秒与损失2.2小时健康生命相关,支持持续改进入院至治疗时间。
研究设计与样本
- 研究为个体患者数据的荟萃分析,纳入7项比较支架取栓装置与药物治疗的随机临床试验。
- 共纳入781例接受取栓治疗的前循环大血管闭塞且最后已知良好时间12小时内的患者。
主要发现
- 早期治疗(最后已知良好至穿刺≤4小时)患者406例(52.0%),晚期治疗(>4-12小时)375例(48.0%)。
- 早期治疗患者中,入院至穿刺中位时间105分钟(IQR 76-135),发病至入院中位时间188分钟(IQR 151.3-214.8)。
- 380例中298例(78.4%)实现显著再灌注,入院至再灌注中位时间145.0分钟(IQR 111.5-185.5)。
- 早期治疗患者中,每延迟10分钟,入院至穿刺损失健康生命年1.8个月,而发病至入院损失0.0个月(P < .001)。
- 每延迟1秒,入院至穿刺损失健康生命2.2小时,入院至再灌注损失2.4小时。
临床怎么用
- 应重点关注入院后流程优化,缩短入院至穿刺和入院至再灌注时间,以减少健康生命年损失。
- 可将每延迟1秒损失2.2小时健康生命作为质量改进的量化依据,推动持续改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The benefits of endovascular thrombectomy (EVT) are time dependent. Prior studies may have underestimated the time-benefit association because time of onset is imprecisely known. OBJECTIVE: To assess the lifetime outcomes associated with speed of endovascular thrombectomy in patients with acute ischemic stroke due to large-vessel occlusion (LVO). DATA SOURCES: PubMed was searched for randomized clinical trials of stent retriever thrombectomy devices vs medical therapy in patients with anterior circulation LVO within 12 hours of last known well time, and for which a peer-reviewed, complete primary results article was published by August 1, 2020. STUDY SELECTION: All randomized clinical trials of stent retriever thrombectomy devices vs medical therapy in patients with anterior circulation LVO within 12 hours of last known well time were included. DATA EXTRACTION/SYNTHESIS: Patient-level data regarding presenting clinical and imaging features and functional outcomes were pooled from the 7 retrieved randomized clinical trials of stent retriever thrombectomy devices (entirely or predominantly) vs medical therapy. All 7 identified trials published in a peer-reviewed journal (by August 1, 2020) contributed data. Detailed time metrics were collected including last known well-to-door (LKWTD) time; last known well/onset-to-puncture (LKWTP) time; last known well-to-reperfusion (LKWR) time; door-to-puncture (DTP) time; and door-to-reperfusion (DTR) time. MAIN OUTCOMES AND MEASURES: Change in healthy life-years measured as disability-adjusted life-years (DALYs). DALYs were calculated as the sum of years of life lost (YLL) owing to premature mortality and years of healthy life lost because of disability (YLD). Disability weights were assigned using the utility-weighted modified Rankin Scale. Age-specific life expectancies without stroke were calculated from 2017 US National Vital Statistics. RESULTS: Among the 781 EVT-treated patients, 406 (52.0%) were early-treated (LKWTP ≤4 hours) and 375 (48.0%) were late-treated (LKWTP >4-12 hours). In early-treated patients, LKWTD was 188 minutes (interquartile range, 151.3-214.8 minutes) and DTP 105 minutes (interquartile range, 76-135 minutes). Among the 298 of 380 (78.4%) patients with substantial reperfusion, median DTR time was 145.0 minutes (interquartile range, 111.5-185.5 minutes). Care process delays were associated with worse clinical outcomes in LKW-to-intervention intervals in early-treated patients and in door-to-intervention intervals in early-treated and late-treated patients, and not associated with LKWTD intervals, eg, in early-treated patients, for each 10-minute delay, healthy life-years lost were DTP 1.8 months vs LKWTD 0.0 months; P < .001. Considering granular time increments, the amount of healthy life-time lost associated with each 1 second of delay was DTP 2.2 hours and DTR 2.4 hours. CONCLUSIONS AND RELEVANCE: In this study, care delays were associated with loss of healthy life-years in patients with acute ischemic stroke treated with EVT, particularly in the postarrival time period. The finding that every 1 second of delay was associated with loss of 2.2 hours of healthy life may encourage continuous quality improvement in door-to-treatment times.
引用
- Almekhlafi MA, Goyal M, Dippel DWJ, et al. Healthy Life-Year Costs of Treatment Speed From Arrival to Endovascular Thrombectomy in Patients With Ischemic Stroke: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical Trials. JAMA Neurol. 2021. PMID: 33938914. doi:10.1001/jamaneurol.2021.1055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。